Polson Ltd to Consider Q2 FY27 Results on November 13, 2026

Polson Ltd will consider standalone unaudited Q2 and H1 FY27 financial results on November 13, 2026, following Q1 FY27 revenue of ₹28 crore, up 18.3% sequentially from ₹24 crore. The board meeting matters because it will provide the next reported update on the specialty chemicals company's operating and profit performance.

When will Polson announce its Q2 FY27 results?

Polson Ltd will hold its board meeting at 2:00 PM on Friday, November 13, 2026, to consider and approve standalone unaudited financial results for the quarter and half year ended September 30, 2026. The company made the board-meeting intimation on November 5 under Regulation 29(1) of the SEBI Listing Obligations and Disclosure Requirements regulations.

The meeting is scheduled at the corporate office at 615/616 Churchgate Chambers, 5 New Marine Lines Road, Churchgate, Mumbai - 400 020. Along with the profit and loss figures, the board will consider the Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report as required under Regulation 33. The agenda also permits consideration of other business with the chair's permission.

The results had not been stated in the information provided. Accordingly, the scheduled meeting should be distinguished from a completed result announcement. The next disclosure is expected to establish the company's reported revenue, profitability and cash-flow position for both the September quarter and the first half of FY27.

What did Polson report in Q1 FY27?

Polson reported Q1 FY27 revenue of ₹28 crore and net profit of ₹1.6 crore for the quarter ended June 2026. Revenue increased 18.3% from ₹24 crore in the March 2026 quarter, while net profit rose 49.1% from ₹1.1 crore on a sequential basis.

Earnings per share for the June quarter stood at ₹133.86, compared with ₹89.94 in the preceding quarter, an increase of 48.8%. The operating margin was 16.3%, lower than 18.4% in March 2026 by 2.1 percentage points. However, net margin improved to 5.7% from 4.5%, a gain of 1.2 percentage points.

The supplied data also describes Q1 revenue growth of 20.25% year-on-year and net-profit growth of 31.15% year-on-year. These figures provide a recent operating reference point ahead of the September-quarter release, although the Q2 outcome will depend on the financial statements approved by the board.

What financial information will the board review?

Polson's board will review standalone unaudited results for the three months and six months ended September 30, 2026. The scope includes the balance-sheet-related Statement of Assets and Liabilities, the Cash Flow Statement and the Limited Review Report, rather than only quarterly revenue and profit figures.

A limited review is relevant because the September period is the first half of the financial year. It gives investors access to financial disclosures covering both the latest quarter and the cumulative six-month period. The board's approval is the formal step before the company's standalone results are released to the exchange.

The meeting notice says the trading window has been closed under Polson's Insider Trading Code and the SEBI Prohibition of Insider Trading Regulations, 2015. The earlier filing indicated that the window would reopen within 48 hours of the results release. This restriction is a standard governance measure around unpublished price-sensitive information.

How has Polson's recent financial trend developed?

Polson's quarterly revenue moved from ₹24 crore in June 2025 to ₹22 crore in September 2025 and December 2025, before returning to ₹24 crore in March 2026 and rising to ₹28 crore in June 2026. The sequence shows that the June 2026 quarter was the highest revenue quarter in the five-quarter data set provided.

Operating profit was shown at ₹2 crore in each of these five quarters. The operating-profit margin in that series ranged from 8.2% in June 2026 to 9.8% in December 2025. Net profit was ₹1 crore in each of the four quarters through March 2026 and ₹2 crore in June 2026, based on the rounded historical figures supplied.

For FY26, Polson reported revenue of ₹91 crore, net profit of ₹4.7 crore, an operating margin of 18.3% and a net margin of 5.2%. The company is identified as operating in specialty chemicals and has been described as a micro-cap company. These characteristics make periodic disclosures particularly important for investors tracking changes in sales, margins and earnings.

Why does the September-quarter release matter to investors?

The September-quarter statement will show whether the revenue improvement seen in June continued into the second quarter. It will also show whether the lower operating-margin figure reported in Q1 was temporary or accompanied by a further change in profitability during the half year.

Investors will be able to compare the approved Q2 figures with the ₹28 crore of Q1 revenue, ₹1.6 crore of Q1 net profit and 16.3% operating margin. The half-year statement will also add cash-flow and balance-sheet disclosures, which are not captured by revenue and net-profit figures alone.

Polson held its 85th Annual General Meeting on September 30, 2026, where all five resolutions were passed unanimously, including adoption of the FY26 audited standalone financial statements and re-appointment of directors. The Q2 board meeting is the next reported corporate event in the supplied timeline, following the company's Q1 FY27 results announced on August 14, 2026.

Conclusion

Polson's November 13 board meeting is scheduled to approve the standalone September-quarter and first-half FY27 financial statements, including limited-review, cash-flow and assets-and-liabilities disclosures. The immediate financial comparison is with Q1 FY27, when revenue reached ₹28 crore and net profit was ₹1.6 crore, alongside an 18.3% sequential increase in revenue.

The principal item to watch is the board-approved Q2 and H1 FY27 release after the 2:00 PM meeting, particularly its revenue, net profit, margins and cash-flow disclosures. The company has also stated that the trading window will reopen within 48 hours of the results release.